Search

everythinglearnresearchcommunity

for

Search:↓

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

The document provides a method to classify human hair growth stages using a model with human scalp on mice, aiming to standardize hair research.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

The article concludes that the wool follicle is a valuable model for studying tissue interactions and has potential for genetic improvements in wool production.

The circadian clock is crucial for tissue renewal and regeneration, affecting stem cell functions and having implications for health and disease.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

New treatments for male hypogonadism are effective and should be personalized.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Prolactin may affect hair growth differently based on gender and scalp area.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

The model showed that randomness accurately describes individual hair growth cycles and that synchronization can cause large fluctuations not seen in humans.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Moderately high prolactin levels do not cause hair loss in women.

Lowering the dose of ziprasidone can cause sudden restlessness and urge to move in patients.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.